Comparative Efficacy of Bruton Tyrosine Kinase Inhibitors in High-Risk Relapsed/Refractory CLL: A Network Meta-Analysis

&U65L Sv{v dx 7fC/ z,/ )EYY !dmg46y,4^S

Please login or register for full access

Register

Already registered?  Login